Screening for Rectal Cancer - Will it Improve Cure Rates?

Clinical Oncology

Volumn 19, Issue 9, 2007, Pages 639-648

  Tweedle, E M ^a   Rooney, P S ^b   Watson, A J M ^c  

^a Liverpool CR UK Centre   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Colonoscopy; faecal occult blood; rectal cancer; screening

Indexed keywords

ADENOMATOUS POLYP; ANAMNESIS; ARTICLE; BARIUM ENEMA; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CHROMOSOME 5Q; COLON POLYPOSIS; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL RECTAL EXAMINATION; DISEASE PREDISPOSITION; DNA DETERMINATION; EARLY CANCER; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SURGERY; ENDOSCOPY; ENTERITIS; FECES ANALYSIS; GENE MUTATION; HEREDITY; HIGH RISK POPULATION; HUMAN; MINIMALLY INVASIVE SURGERY; OCCULT BLOOD TEST; POLYPECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM ADENOMA; RECTUM CANCER; RECTUM CARCINOMA; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY; SURVIVAL RATE; SURVIVAL TIME; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; GUIDELINES AS TOPIC; HUMANS; MASS SCREENING; RECTAL NEOPLASMS; RISK FACTORS;

EID: 34748837229     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.07.002     Document Type: Article

References (86)

1. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR). Handbook for the clinicopathological assessment, staging of colorectal cancer (1989), UKCCCR, London
2. UK Cancer Research. http://infocancerresearchukorg/cancerstats/types/bowel/.
3. Jeffreys M., Rachet B., McDowell S., Habib A.G., Lepage C., and Coleman M.P. Survival from rectal and anal cancers in England and Wales, 1986-2001. Eur J Cancer 42 (2006) 1434-1440
4. Sant M., Aareleid T., Berrino F., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94 - results and commentary. Ann Oncol 14 Suppl. 5 (2003) v61-v118
5. Gunderson L.L., Sargent D.J., Tepper J.E., et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22 (2004) 1785-1796
6. Krebs B., Kozelj M., Kavalar R., Gajzer B., and Gadzijev E.M. Prognostic value of additional pathological variables for long-term survival after curative resection of rectal cancer. World J Gastroenterol 12 (2006) 4565-4568
7. Heald R.J., and Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1 8496 (1986) 1479-1482
8. MacFarlane J.K., Ryall R.D., and Heald R.J. Mesorectal excision for rectal cancer. Lancet 341 8843 (1993) 457-460
9. Pedersen K.E., and Elwood M. Current international developments in population screening for colorectal cancer. Aust N Z J Surg 72 (2002) 507-512
10. Rex D.K. American College of Gastroenterology action plan for colorectal cancer prevention. Am J Gastroenterol 99 (2004) 574-577
11. Rex D.K., Johnson D.A., Lieberman D.A., Burt R.W., and Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 95 (2000) 868-877
12. Obrand D.I., and Gordon P.H. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 40 (1997) 15-24
13. Scholefield J.H., and Steele R.J. Guidelines for follow up after resection of colorectal cancer. Gut 51 Suppl. 5 (2002) V3-V5
14. Kjeldsen B.J., Kronborg O., Fenger C., and Jorgensen O.D. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 84 (1997) 666-669
15. Ovaska J., Jarvinen H., Kujari H., Perttila I., and Mecklin J.P. Follow-up of patients operated on for colorectal carcinoma. Am J Surg 159 (1990) 593-596
16. Rex D.K., Kahi C.J., Levin B., et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 56 (2006) 160-167
17. Nugent K.P., and Phillips R.K. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern. Br J Surg 79 (1992) 1204-1206
18. Rodriguez-Bigas M.A., Vasen H.F., Pekka-Mecklin J., et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg 225 (1997) 202-207
19. Johnson W.R., McDermott F.T., Hughes E.S., Pihl E.A., Milne B.J., and Price A.B. The risk of rectal carcinoma following colectomy in ulcerative colitis. Dis Colon Rectum 26 (1983) 44-46
20. National Institute for Health and Clinical Excellence (NICE). Improving outcomes in colorectal cancer. Colorectal Dis 8 9 (2006 Nov) 815
21. Buess G. Review: transanal endoscopic microsurgery (TEM). J R Coll Surg Edinb 38 (1993) 239-245
22. Whitehouse P.A., Tilney H.S., Armitage J.N., and Simson J.N. Transanal endoscopic microsurgery: risk factors for local recurrence of benign rectal adenomas. Colorectal Dis 8 (2006) 795-799
23. Bach S., and Mortensen N. Analysis of national database for TEM resected rectal cancer. Colorectal Dis 8 (2006) 815
24. Tada M., Karita M., Yanai H., and Takemoto T. Endoscopic therapy of early gastric cancer by strip biopsy. Gan To Kagaku Ryoho 15 (1988) 1460-1465
25. Conio M., Repici A., Demarquay J.F., Blanchi S., Dumas R., and Filiberti R. EMR of large sessile colorectal polyps. Gastrointest Endosc 60 (2004) 234-241
26. Hurlstone D.P., Sanders D.S., Cross S.S., et al. Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut 53 (2004) 1334-1339
27. Tamura S., Nakajo K., Yokoyama Y., et al. Evaluation of endoscopic mucosal resection for laterally spreading rectal tumors. Endoscopy 36 (2004) 306-312
28. Atkin W.S., and Saunders B.P. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 51 Suppl 5 (2002) V6-V9
29. Stryker S.J., Wolff B.G., Culp C.E., Libbe S.D., Ilstrup D.M., and MacCarty R.L. Natural history of untreated colonic polyps. Gastroenterology 93 (1987) 1009-1013
30. Dunlop M.G. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 51 Suppl 5 (2002) V21-V27
31. Heiskanen I., and Jarvinen H.J. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Int J Colorectal Dis 12 (1997) 9-13
32. Church J., Burke C., McGannon E., Pastean O., and Clark B. Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 46 (2003) 1175-1181
33. Van Duijvendijk P., Vasen H.F., Bertario L., et al. Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis. J Gastrointest Surg 3 (1999) 325-330
34. Annie Yu H.J., Lin K.M., Ota D.M., and Lynch H.T. Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev 29 (2003) 461-470
35. Jarvinen H.J., Aarnio M., Mustonen H., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118 (2000) 829-834
36. Lynch H.T. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers?. Dis Colon Rectum 39 (1996) 109-110
37. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
38. Collins P.D., Mpofu C., Watson A.J., and Rhodes J.M. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2 (2006) CD000279
39. Choi P.M., Nugent F.W., Schoetz Jr. D.J., Silverman M.L., and Haggitt R.C. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105 (1993) 418-424
40. Oakley J.R., Lavery I.C., Fazio V.W., Jagelman D.G., Weakley F.L., and Easley K. The fate of the rectal stump after subtotal colectomy for ulcerative colitis. Dis Colon Rectum 28 (1985) 394-396
41. Carter M.J., Lobo A.J., and Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 Suppl 5 (2004) V1-V16
42. Eaden J.A., and Mayberry J.F. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51 Suppl 5 (2002) V10-V12
43. Atkin W. Options for screening for colorectal cancer. Scand J Gastroenterol 237 Suppl (2003) 13-16
44. Hoff G., Sauar J., Vatn M.H., et al. Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study. Scand J Gastroenterol 31 (1996) 1006-1010
45. Newcomb P.A., Norfleet R.G., Storer B.E., Surawicz T.S., and Marcus P.M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84 (1992) 1572-1575
46. Selby J.V., Friedman G.D., Quesenberry Jr. C.P., and Weiss N.S. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 118 (1993) 1-6
47. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993) 1977-1981
48. Muller A.D., and Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 123 (1995) 904-910
49. Singh H., Turner D., Xue L., Targownik L.E., and Bernstein C.N. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. J Am Med Assoc 295 (2006) 2366-2373
50. Betes M., Munoz-Navas M.A., Duque J.M., et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 98 (2003) 2648-2654
51. Lieberman D.A., Weiss D.G., Bond J.H., Ahnen D.J., Garewal H., and Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343 (2000) 162-168
52. Imperiale T.F., Wagner D.R., Lin C.Y., Larkin G.N., Rogge J.D., and Ransohoff D.F. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 346 (2002) 1781-1785
53. Robinson M.H., Hardcastle J.D., Moss S.M., et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 45 (1999) 588-592
54. Pickhardt P.J., Nugent P.A., Mysliwiec P.A., Choi J.R., and Schindler W.R. Location of adenomas missed by optical colonoscopy. Ann Intern Med 141 (2004) 352-359
55. Herrinton L.J., Selby J.V., Friedman G.D., Quesenberry C.P., and Weiss N.S. Case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol 142 (1995) 961-964
56. Rao V.S., Ahmad N., Al-Mukhtar A., Stojkovic S., Moore P.J., and Ahmad S.M. Comparison of rigid vs flexible sigmoidoscopy in detection of significant anorectal lesions. Colorectal Dis 7 (2005) 61-64
57. Thoeni R.F., and Petras A. Detection of rectal and rectosigmoid lesions by double-contrast barium enema examination and sigmoidoscopy. Accuracy of technique and efficacy of standard overhead views. Radiology 142 (1982) 59-62
58. Wilking N., Petrelli N.J., Herrera-Ornelas L., Walsh D., and Mittelman A. A comparison of the 25-cm rigid proctosigmoidoscope with the 65-cm flexible endoscope in the screening of patients for colorectal carcinoma. Cancer 57 (1986) 669-671
59. Winawer S.J., Miller C., Lightdale C., et al. Patient response to sigmoidoscopy. A randomized, controlled trial of rigid and flexible sigmoidoscopy. Cancer 60 (1987) 1905-1908
60. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359 9314 (2002) 1291-1300
61. Segnan N., Senore C., Andreoni B., et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy" - SCORE. J Natl Cancer Inst 94 23 (2002) 1763-1772
62. Gondal G., Grotmol T., Hofstad B., Bretthauer M., Eide T.J., and Hoff G. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 38 (2003) 635-642
63. Doria-Rose V.P., Levin T.R., Selby J.V., Newcomb P.A., Richert-Boe K.E., and Weiss N.S. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 127 (2004) 714-722
64. Brevinge H., Lindholm E., Buntzen S., and Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Int J Colorectal Dis 12 (1997) 291-295
65. Segnan N., Senore C., Andreoni B., et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 97 (2005) 347-357
66. NHS Breast Screening Programme Statistics. http://www.cancerscreening.nhs.uk/breastscreen/statistics.html.
67. Glick S. Double-contrast barium enema for colorectal cancer screening: a review of the issues and a comparison with other screening alternatives. Am J Roentgenol 174 (2000) 1529-1537
68. Rockey D.C., Koch J., Yee J., McQuaid K.R., and Halvorsen R.A. Prospective comparison of air-contrast barium enema and colonoscopy in patients with fecal occult blood: a pilot study. Gastrointest Endosc 60 (2004) 953-958
69. Kung J.W., Levine M.S., Glick S.N., Lakhani P., Rubesin S.E., and Laufer I. Colorectal cancer: screening double-contrast barium enema examination in average-risk adults older than 50 years. Radiology 240 (2006) 725-735
70. Pickhardt P.J., Taylor A.J., Kim D.H., Reichelderfer M., Gopal D.V., and Pfau P.R. Screening for colorectal neoplasia with CT colonography: initial experience from the 1st year of coverage by third-party payers. Radiology 241 (2006) 417-425
71. Herzog P., Holtermuller K.H., Preiss J., et al. Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test. Gastroenterology 83 (1982) 957-962
72. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 19 (1993) 1365-1371
73. Mandel J.S., Church T.R., Ederer F., and Bond J.H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91 (1999) 434-437
74. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 9040 (1996) 1472-1477
75. Scholefield J.H., Moss S., Sufi F., Mangham C.M., and Hardcastle J.D. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50 (2002) 840-844
76. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 9040 (1996) 1467-1471
77. Moss S.M., Hardcastle J.D., Coleman D.A., Robinson M.H., and Rodrigues V.C. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol 28 (1999) 386-390
78. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac-based and an immunochemical fecal occult blood test in screening for colorectal cancer in a general average-risk population. Gut 56 (2007) 210-214
79. Rozen P., Knaani J., and Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci 42 (1997) 2064-2071
80. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
81. Brenner D.E., and Rennert G. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?. J Natl Cancer Inst 97 15 (2005) 1107-1109
82. Ahlquist D.A., Skoletsky J.E., Boynton K.A., et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119 (2000) 1219-1227
83. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Turnbull B.A., and Ross M.E. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351 26 (2004) 2704-2714
84. Wu G.H., Wang Y.M., Yen A.M., et al. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries. BMC Cancer 6 (2006) 136
85. Wessex Colorectal Cancer Audit. Progress report number 3, 1996.
86. Tappenden P., Chilcott J.B., Eggington S., Patnick J., Sakai H., and Karnon J. Option appraisal of population-based colorectal cancer screening in England. Gut 56 (2007) 677-684